Skip to content
OpenCapital
Get started

Evolus EOLS Free cash flow margin

Free cash flow margin at other companies

AbbVie logo
AbbVieABBV
31.8%+5.0pp

Other financials

Income statement

See full
Revenue$73.1M+6.7%
Gross profit$48.9M+4.8%
Operating income-$6.8M+54.9%
Net income-$10.7M+43.5%
EPS (diluted)-$0.16+46.7%

Balance sheet

See full
Cash & equivalents$49.8M-26.7%
Total debt$164.9M-4.1%
Total equity-$28.8M-336%
Total assets$220.6M+3.4%

Cash flow

See full
Operating cash flow-$10.0M+36.3%
CapEx$415.0K+30.1%
Free cash flow-$10.4M+35.0%

Valuation

See full
Market cap$470.86M-21.3%
Enterprise value$585.97M-16.6%
P/S1.6×-0.6×

Profitability

See full
Gross margin66.1%-2.4pp
Operating margin-13.7%-1.9pp
Net margin-14.4%-3.3pp

Returns & leverage

See full
Return on equity-472.6%-1,534pp
Debt / equity22.2×—
Current ratio2×-0.3×

Where this comes from

Calculated from Evolus’s reported figures.

free cash flow/total revenue=-9.6%

Based on trailing twelve months.

The official record: Evolus’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Evolus's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolus's free cash flow margin?
Evolus (EOLS) reported free cash flow margin of -9.6% in Q3 2024.
How has Evolus's free cash flow margin changed year-over-year?
Evolus's free cash flow margin increased by 60.3% year-over-year, from -24.2% to -9.6%.
What is the long-term trend for Evolus's free cash flow margin?
Over 3 years (2020 to 2023), Evolus's free cash flow margin has grown at a -44.9% compound annual growth rate (CAGR), from -103.8% to -17.4%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.